Annals of Noninvasive Electrocardiology (Jan 2023)

Effects of different interventions on prognosis and quality of life in patients with atrial fibrillation

  • Hongxia Wang,
  • Jiajun Huang,
  • Wenxi Gu,
  • Xiaojiao Hao,
  • Guiru Li,
  • Yumin Yuan,
  • Yingmin Lu

DOI
https://doi.org/10.1111/anec.13031
Journal volume & issue
Vol. 28, no. 1
pp. n/a – n/a

Abstract

Read online

Abstract Objective To compare the effects of different intervention measures on prognosis and quality of life in patients with atrial fibrillation, in order to provide clinical basis for diagnosis and treatment. Methods A total of 160 patients who visited several hospitals including Shanghai Xinhua Hospital from June 2019 to June 2021 were selected. Among them, 40 cases were in the drug treatment group (DRUG group), 40 cases in the radiofrequency ablation group (Radiofrequency ablation, RFA group), and 40 cases in the catheter ablation combined with percutaneous left atrial appendage occlusion group (“"one‐stop”" procedure group) and 40 cases in the percutaneous left atrial appendage closure group (Left atrial appendage closure, LAAC group). The Minnesota quality of life score (MLHFQ), ejection fraction (LVEF), and left atrial anterior and posterior diameters (LAD) were compared between the groups at 1‐year follow‐up, and the differences in adverse events were compared between the groups. Results (1) After a 1‐year follow‐up, overall comparison, the MLHFQ scores and the LVEF and the LAD among the four groups were statistically different (p .05); in the LAAC group, the MLHFQ scores was increased, the LVEF was decreased, and the LAD was increased (p < .01). (4) There were significant differences in the incidence of adverse events among the four groups (p < .01), the lowest in the RFA group and the highest in the LAAC group. Conclusion Compared with drug treatment, radiofrequency ablation and “one‐stop” procedure group can improve the quality of life of patients with atrial fibrillation, improve cardiac function, and reduce the occurrence of adverse events. Percutaneous left atrial appendage occlusion affects patients' quality of life and improves cardiac function, and increases the incidence of adverse events.

Keywords